32 C-reactive protein (CRP) as a prognostic biomarker in advanced non-small cell lung cancer treated with immune checkpoint inhibitors. Results from a multi-center international observational study - Abdul Rafeh Naqash; Mahvish Muzaffar; Shravanti Macherla; Alessio Cortellini; James Clark; Emma Mi; Sanna Livanainen; Daria Gramenitskaya; Kevin O’Brien; Jussi Koivunen; Sweta Jonnalagadda; Shanker Polsani; et al. (Journal for ImmunoTherapy of Cancer, 2020)